Autor(es): Lima, Tânia ; Perpétuo, Luís ; Henrique, Rui ; Fardilha, Margarida ; Leite-Moreira, Adelino ; Bastos, Jose ; Vitorino, Rui
Data: 2023
Identificador Persistente: http://hdl.handle.net/10773/40047
Origem: RIA - Repositório Institucional da Universidade de Aveiro
Assunto(s): Biomarker; Diagnosis; Galectin-3; Heart diseases; Prognosis; Prostate cancer
Galectin-3 (Gal-3) belongs to galectin protein family, a type of β-galactose-binding lectin having more than one evolutionarily conserved domain of carbohydrate recognition. Gal-3 is mainly located in the cytoplasm, but it also enters the nucleus and is secreted into the extracellular environment and biological fluids such as urine, saliva, and serum. It plays an important role in many biological functions, such as angiogenesis, apoptosis, cell differentiation, cell growth, fibrosis, inflammation, host defense, cellular modification, splicing of pre-mRNA, and transformation. Many previous studies have shown that Gal-3 can be used as a diagnostic or prognostic biomarker for heart ailments, kidney diseases, and other major illnesses including cancer. Moreover, it may also play a major role in risk stratification in different diseases, and in this review, we have summarized the potential roles and application of Gal-3 as diagnostic, prognostic, and risk stratifying biomarker from previously reported studies in heart diseases and cancer, with special emphasis on prostate cancer.
